| Primary |
| Renal Cancer Metastatic |
33.3% |
| Renal Cell Carcinoma |
16.7% |
| Non-small Cell Lung Cancer |
10.8% |
| Renal Cell Carcinoma Stage Unspecified |
5.8% |
| Colon Cancer Metastatic |
5.0% |
| Neoplasm Malignant |
4.2% |
| Prostate Cancer |
3.3% |
| Bladder Cancer |
2.5% |
| Gastrointestinal Stromal Tumour |
2.5% |
| Renal Cancer |
2.5% |
| Head And Neck Cancer |
1.7% |
| Hypertension |
1.7% |
| Leiomyosarcoma Metastatic |
1.7% |
| Metastatic Neoplasm |
1.7% |
| Metastatic Renal Cell Carcinoma |
1.7% |
| Pain |
1.7% |
| Anaemia |
0.8% |
| Breast Cancer |
0.8% |
| Breast Cancer Metastatic |
0.8% |
| Cancer |
0.8% |
|
| Thrombocytopenia |
12.1% |
| Vomiting |
12.1% |
| Pleural Effusion |
8.6% |
| Pyrexia |
6.9% |
| Oedema Peripheral |
5.2% |
| Small Intestinal Obstruction |
5.2% |
| Ventricular Extrasystoles |
5.2% |
| Atrial Fibrillation |
3.4% |
| Diverticulitis |
3.4% |
| Dyspnoea |
3.4% |
| Haematuria |
3.4% |
| Intestinal Perforation |
3.4% |
| Malignant Pleural Effusion |
3.4% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.4% |
| Pancreatitis Acute |
3.4% |
| Platelet Count Decreased |
3.4% |
| Pulmonary Embolism |
3.4% |
| Renal Mass |
3.4% |
| Staphylococcal Infection |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
|
| Secondary |
| Colorectal Cancer Metastatic |
14.1% |
| Renal Cell Carcinoma |
11.9% |
| Product Used For Unknown Indication |
10.9% |
| Colorectal Cancer |
6.2% |
| Breast Cancer |
6.0% |
| Prostate Cancer |
5.4% |
| Drug Use For Unknown Indication |
5.2% |
| Hypertension |
5.2% |
| Gastrointestinal Stromal Tumour |
5.1% |
| Pain |
4.6% |
| Non-small Cell Lung Cancer |
4.1% |
| Metastatic Renal Cell Carcinoma |
3.6% |
| Renal Cancer Metastatic |
3.5% |
| Gastric Cancer |
2.9% |
| Thymoma |
2.2% |
| Thymoma Malignant |
2.2% |
| Deep Vein Thrombosis |
1.9% |
| Nausea |
1.7% |
| Constipation |
1.6% |
| Renal Cancer |
1.6% |
|
| Vomiting |
21.9% |
| Proteinuria |
7.0% |
| Mucosal Inflammation |
6.1% |
| Pyrexia |
6.1% |
| Death |
5.3% |
| Hyponatraemia |
5.3% |
| Pneumonia |
5.3% |
| Thrombocytopenia |
5.3% |
| Pulmonary Embolism |
4.4% |
| Pain |
3.5% |
| Rash |
3.5% |
| Subdural Haematoma |
3.5% |
| Therapeutic Response Decreased |
3.5% |
| Urinary Tract Infection |
3.5% |
| Cerebral Infarction |
2.6% |
| Delusion |
2.6% |
| Flank Pain |
2.6% |
| Hypoaesthesia Facial |
2.6% |
| Lethargy |
2.6% |
| Respiratory Failure |
2.6% |
|
| Concomitant |
| Renal Cell Carcinoma |
29.2% |
| Nausea |
14.9% |
| Metastatic Renal Cell Carcinoma |
7.7% |
| Hypertension |
4.8% |
| Anxiety |
4.2% |
| Constipation |
4.2% |
| Neoplasm Malignant |
4.2% |
| Pain |
4.2% |
| Convulsion |
3.6% |
| Drug Use For Unknown Indication |
3.0% |
| Gastrointestinal Stromal Tumour |
2.4% |
| Hypothyroidism |
2.4% |
| Neoplasm |
2.4% |
| Nuclear Magnetic Resonance Imaging |
2.4% |
| Product Used For Unknown Indication |
2.4% |
| Cardiac Failure |
1.8% |
| Enterocolitis Haemorrhagic |
1.8% |
| Ewing's Sarcoma |
1.8% |
| Metastatic Carcinoid Tumour |
1.8% |
| Analgesic Therapy |
1.2% |
|
| Renal Cell Carcinoma |
16.7% |
| Retroperitoneal Lymphadenopathy |
13.9% |
| Diarrhoea |
5.6% |
| Hypertensive Emergency |
5.6% |
| Hyponatraemia |
5.6% |
| Oral Pain |
5.6% |
| Skin Fibrosis |
5.6% |
| Sudden Death |
5.6% |
| Thrombocytopenia |
5.6% |
| Angioedema |
2.8% |
| Cardiovascular Disorder |
2.8% |
| Cerebrovascular Accident |
2.8% |
| Cholinergic Syndrome |
2.8% |
| Death |
2.8% |
| Dental Caries |
2.8% |
| Disease Progression |
2.8% |
| Epistaxis |
2.8% |
| Fatigue |
2.8% |
| Hypersensitivity |
2.8% |
| Hypertension |
2.8% |
|
| Interacting |
| Prostate Cancer |
38.6% |
| Drug Use For Unknown Indication |
9.1% |
| Hypertension |
9.1% |
| Metastatic Renal Cell Carcinoma |
6.8% |
| Product Used For Unknown Indication |
6.8% |
| Headache |
5.7% |
| Insomnia |
5.7% |
| Gastrointestinal Stromal Tumour |
4.5% |
| Hypothyroidism |
4.5% |
| Asthma |
3.4% |
| Renal Cell Carcinoma |
2.3% |
| Gastrointestinal Cancer Metastatic |
1.1% |
| Metastases To Bone |
1.1% |
| Thyroid Function Test Abnormal |
1.1% |
|
| Neutropenia |
19.0% |
| Psychotic Disorder |
19.0% |
| Renal Failure |
19.0% |
| Delusion |
9.5% |
| Sleep Disorder |
9.5% |
| Thrombocytopenia |
9.5% |
| Haematotoxicity |
4.8% |
| Hepatic Failure |
4.8% |
| Potentiating Drug Interaction |
4.8% |
|
